Free Trial

Bruker (BRKR) Competitors

Bruker logo
$36.98 +2.15 (+6.17%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$37.51 +0.53 (+1.43%)
As of 10/3/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BRKR vs. TECH, A, IQV, MTD, RVTY, TMO, WAT, ILMN, BIO, and CRL

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Bio-Techne (TECH), Agilent Technologies (A), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), and Charles River Laboratories International (CRL).

Bruker vs. Its Competitors

Bio-Techne (NASDAQ:TECH) and Bruker (NASDAQ:BRKR) are both mid-cap life sciences tools & services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

In the previous week, Bruker had 2 more articles in the media than Bio-Techne. MarketBeat recorded 12 mentions for Bruker and 10 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.80 beat Bruker's score of 0.51 indicating that Bio-Techne is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Techne
4 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bruker
5 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Bio-Techne has a net margin of 6.02% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Bio-Techne's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Techne6.02% 13.43% 10.32%
Bruker 2.31%17.89%5.38%

Bio-Techne currently has a consensus target price of $70.42, indicating a potential upside of 11.86%. Bruker has a consensus target price of $51.00, indicating a potential upside of 37.91%. Given Bruker's higher probable upside, analysts clearly believe Bruker is more favorable than Bio-Techne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Techne
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64
Bruker
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays out 69.6% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Bruker has higher revenue and earnings than Bio-Techne. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Techne$1.22B8.04$73.40M$0.46136.85
Bruker$3.44B1.63$113.10M$0.5271.12

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by company insiders. Comparatively, 27.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bio-Techne has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.

Summary

Bio-Techne beats Bruker on 10 of the 19 factors compared between the two stocks.

Get Bruker News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$5.28B$913.42M$32.69B$10.57B
Dividend Yield0.58%0.58%3.18%4.70%
P/E Ratio71.1220.37445.6426.69
Price / Sales1.631.16182,503.27177.92
Price / Cash9.7018.9637.6061.25
Price / Book3.122.377.416.55
Net Income$113.10M$17.67M$816.64M$277.52M
7 Day Performance19.14%5.56%3.25%2.36%
1 Month Performance24.14%6.53%10.72%9.27%
1 Year Performance-44.81%-19.25%24,009.41%30.77%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRKR
Bruker
4.9629 of 5 stars
$36.98
+6.2%
$51.00
+37.9%
-43.8%$5.28B$3.44B71.1211,396News Coverage
Analyst Forecast
TECH
Bio-Techne
4.7136 of 5 stars
$52.23
+0.7%
$70.42
+34.8%
-14.9%$8.13B$1.22B113.553,100Positive News
A
Agilent Technologies
3.7063 of 5 stars
$123.70
+0.3%
$140.08
+13.2%
-1.8%$35.07B$6.51B29.0417,900Ex-Dividend
Analyst Forecast
IQV
IQVIA
4.8223 of 5 stars
$181.00
+0.8%
$229.64
+26.9%
-9.1%$30.77B$15.41B26.1988,000Positive News
Analyst Forecast
MTD
Mettler-Toledo International
3.9822 of 5 stars
$1,191.70
-1.1%
$1,325.56
+11.2%
-10.2%$24.55B$3.87B30.1817,300Positive News
Analyst Forecast
RVTY
Revvity
3.8889 of 5 stars
$84.23
+0.2%
$119.29
+41.6%
-24.1%$9.78B$2.76B35.6911,000Analyst Forecast
TMO
Thermo Fisher Scientific
4.8658 of 5 stars
$461.95
-0.5%
$588.35
+27.4%
-9.5%$174.44B$42.88B26.72125,000Positive News
Analyst Forecast
Options Volume
WAT
Waters
4.5508 of 5 stars
$289.19
-0.9%
$378.73
+31.0%
-7.2%$17.21B$2.96B26.087,600Trending News
ILMN
Illumina
4.7465 of 5 stars
$91.87
+0.2%
$123.06
+33.9%
-25.1%$14.12B$4.37B11.639,030Analyst Forecast
BIO
Bio-Rad Laboratories
4.2242 of 5 stars
$269.95
-0.5%
$333.50
+23.5%
-9.4%$7.30B$2.57B23.017,700
CRL
Charles River Laboratories International
4.2562 of 5 stars
$146.88
-1.1%
$177.07
+20.6%
-6.4%$7.23B$4.05B-110.4320,100News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners